GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sprint Bioscience AB (OSTO:SPRINT) » Definitions » Cyclically Adjusted FCF per Share

Sprint Bioscience AB (OSTO:SPRINT) Cyclically Adjusted FCF per Share : kr-1.80 (As of Jun. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Sprint Bioscience AB Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Sprint Bioscience AB's adjusted free cash flow per share for the three months ended in Jun. 2024 was kr-0.052. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr-1.80 for the trailing ten years ended in Jun. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2024-09-21), Sprint Bioscience AB's current stock price is kr1.17. Sprint Bioscience AB's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2024 was kr-1.80. Sprint Bioscience AB's Cyclically Adjusted Price-to-FCF of today is .


Sprint Bioscience AB Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Sprint Bioscience AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sprint Bioscience AB Cyclically Adjusted FCF per Share Chart

Sprint Bioscience AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -1.86

Sprint Bioscience AB Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.98 -1.88 -1.86 -1.83 -1.80

Competitive Comparison of Sprint Bioscience AB's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Sprint Bioscience AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sprint Bioscience AB's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sprint Bioscience AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Sprint Bioscience AB's Cyclically Adjusted Price-to-FCF falls into.



Sprint Bioscience AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sprint Bioscience AB's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=-0.052/132.7160*132.7160
=-0.052

Current CPI (Jun. 2024) = 132.7160.

Sprint Bioscience AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201409 -0.530 100.161 -0.702
201412 -0.619 100.225 -0.820
201503 -0.533 99.950 -0.708
201506 -0.698 99.995 -0.926
201509 1.463 100.228 1.937
201512 -0.842 100.276 -1.114
201603 -0.787 100.751 -1.037
201606 -0.684 101.019 -0.899
201609 2.084 101.138 2.735
201612 -0.918 102.022 -1.194
201703 -0.966 102.022 -1.257
201706 -0.784 102.752 -1.013
201709 -0.476 103.279 -0.612
201712 -0.977 103.793 -1.249
201803 0.804 103.962 1.026
201806 -1.010 104.875 -1.278
201809 -1.055 105.679 -1.325
201812 -0.876 105.912 -1.098
201903 -1.078 105.886 -1.351
201906 -0.794 106.742 -0.987
201909 0.470 107.214 0.582
201912 -0.762 107.766 -0.938
202003 0.116 106.563 0.144
202006 -0.952 107.498 -1.175
202009 -0.566 107.635 -0.698
202012 -0.537 108.296 -0.658
202103 -0.537 108.360 -0.658
202106 -1.029 108.928 -1.254
202109 0.378 110.338 0.455
202112 -0.344 112.486 -0.406
202203 -0.343 114.825 -0.396
202206 -0.390 118.384 -0.437
202209 -0.369 122.296 -0.400
202212 0.000 126.365 0.000
202303 -0.032 127.042 -0.033
202306 -0.169 129.407 -0.173
202309 0.567 130.224 0.578
202312 -0.038 131.912 -0.038
202403 -0.144 132.205 -0.145
202406 -0.052 132.716 -0.052

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Sprint Bioscience AB  (OSTO:SPRINT) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Sprint Bioscience AB Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Sprint Bioscience AB's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Sprint Bioscience AB Business Description

Industry
Traded in Other Exchanges
Address
Halsovagen 7, Floor 8, Elevator A, Novum, Huddinge, SWE, 141 57
Sprint Bioscience AB is a Sweden based company involved in developing drugs focused on cancer and metabolism. The project portfolio of the company includes STK25, VPS34, and PIP4K2.

Sprint Bioscience AB Headlines

No Headlines